Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

On Friday, Governor Josh Shapiro and Pennsylvania Department of Community & Economic Development (DCED) Secretary Rick Siger ...

According to fund sponsor T. Rowe Price, managers invest in four main categories: Pharmaceuticals, health care companies, ...

Despite facing near-term financial pressures, the healthcare sector’s growth prospects for 2026 remain optimistic, fueled by demographic tailwinds and therapeutic innovation. For investors looking ...

Shares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.

The VanEck Pharmaceutical ETF (NYSEARCA:PPH) has surged 26% over the past year, driven almost entirely by the weight-loss ...

Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain ...

The current generation of deals, which is likely to involve AbbVie (NYSE: ABBV), Merck & Co Inc (NYSE: MRK), Bristol-Myers Squibb Co (NYSE: BMY), and Gilead Sciences Inc (NYSE: GILD), is focused on ...